Amedeo Smart

Free Medical Literature Service


 

Amedeo

Multiple Sclerosis

  Free Subscription

11.05.2026

1 BMC Neurol
1 Can J Neurol Sci
1 J Neuroimmunol
2 J Neurol
1 J Neurol Neurosurg Psychiatry
2 J Neurol Sci
1 Mult Scler
3 Neurology



    BMC Neurol

  1. ABBASI KASBI N, Rezaeimanesh N, Khodadadi S, Nikkhah Bahrami S, et al
    The influence of adolescent diet on the occurrence of late-onset multiple sclerosis: a population-based case-control study.
    BMC Neurol. 2026 May 2. doi: 10.1186/s12883-026-04919.
    >> Share


    Can J Neurol Sci

  2. FREEDMAN DE, Oh J, David J, Feinstein A, et al
    Smoked nicotine use is associated with depressive symptoms in women with multiple sclerosis.
    Can J Neurol Sci. 2026 May 7:1-9. doi: 10.1017/cjn.2026.10617.
    >> Share


    J Neuroimmunol

  3. PLESA A, Maruntelu I, Sirbu OM, Constantinescu I, et al
    MicroRNA profiles in multiple sclerosis: A review of the literature.
    J Neuroimmunol. 2026;417:578946.
    >> Share


    J Neurol

  4. DE JONG DJ, Molenaar PCG, Verhoef V, Novakova L, et al
    The practice effect of smartphone-derived cognitive processing speed assessments as a proxy of cognitive functioning in multiple sclerosis.
    J Neurol. 2026;273:305.
    >> Share

  5. MAGGI G, Altieri M, d'Ambrosio A, Risi M, et al
    Refining neuropsychological assessment strategies in multiple sclerosis: insights from long-term cognitive trajectories.
    J Neurol. 2026;273:304.
    >> Share


    J Neurol Neurosurg Psychiatry

  6. FISCHBACH F, Richter J, Korporal-Kuhnke M, Pfeffer LK, et al
    Autologous haematopoietic stem cell transplantation in multiple sclerosis: outcomes and predictors from German real-world data.
    J Neurol Neurosurg Psychiatry. 2026 May 6:jnnp-2025-338129.
    >> Share


    J Neurol Sci

  7. SAHIN A, Ismah, Herawati AA, Mubarak MA, et al
    Methodological considerations in evaluating lifetime estrogen exposure and neurodegeneration in multiple sclerosis.
    J Neurol Sci. 2026;486:125963.
    >> Share

  8. GELISSEN LMY, Wijburg MT, Strijbis EMM, de Jong BA, et al
    No interferon-beta antibodies in natalizumab-treated multiple sclerosis patients with progressive multifocal leukoencephalopathy.
    J Neurol Sci. 2026;486:125947.
    >> Share


    Mult Scler

  9. LEVRAUT M, Cohen M, Sterlin D, Ayrignac X, et al
    Kappa free light chain index or oligoclonal bands testing in clinical practice for multiple sclerosis diagnosis: An algorithm comparative study.
    Mult Scler. 2026 May 6:13524585261442020. doi: 10.1177/13524585261442020.
    >> Share


    Neurology

  10. GAVOILLE A, Kerbrat A, Edan G, Le Page E, et al
    Differences in Use of Disease-Modifying Therapies Between Patients With Late-Onset and Adult-Onset Relapsing-Remitting Multiple Sclerosis.
    Neurology. 2026;106:e214943.
    >> Share

  11. PLUCHINO S, Mozafari S
    Early Human Intrathecal Mesenchymal Stem Cell Study in Progressive Multiple Sclerosis Faces Delivery Challenges.
    Neurology. 2026;106:e214955.
    >> Share

  12. KVISTAD CE, Krakenes T, Holmoy T, Eidem LE, et al
    Intrathecal Mesenchymal Stem Cells in Progressive Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial (SMART-MS).
    Neurology. 2026;106:e214915.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016